Overview

Treatment of Acute Migraine Headache in Children

Status:
Completed
Trial end date:
2010-03-01
Target enrollment:
0
Participant gender:
All
Summary
Migraine is common in children and is one of the most common etiologies of headache leading to emergency room presentation in children. Despite this, few studies have investigated the treatment of acute migraine headache in the emergency room. We will perform a prospective, double-blind, placebo-controlled study of metoclopramide versus placebo in the treatment of acute migraine headache. The primary outcome will be the number of subjects headache free at two hours.
Phase:
Phase 2
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Children's Hospital of Philadelphia
Treatments:
Metoclopramide
Criteria
Inclusion Criteria:

1. Males or Females age 8-18 years

2. Girls 11 years or older must have a negative urine/serum pregnancy test.

3. Diagnosis of pediatric migrainous headache. The criteria for pediatric migraine
headache based on the most recent ICHD criteria are listed below. The requirement of 5
attacks (A) will not be required for this study, this making the diagnosis migrainous
headache. As described elsewhere in the protocol, this change is required to make the
study applicable to ED patients who require treatment before five attacks have
occurred.

Exclusion Criteria:

1. Evidence that headache is due to a secondary underlying disorder based on history or
physical examination.

2. Pregnant or lactating females.

3. Any investigational drug use within 30 days.

4. Known to have a contraindication to metoclopramide or valproic acid such as pregnancy,
liver disease, hematologic disease, or metabolic disease.

5. Have used metoclopramide (or other antidopaminergic medications) or valproic acid
within two days of presentation.

6. Severe developmental disorders or mental retardation if insufficient information can
be obtained to make a clear diagnosis of migraine or judge headache severity.

7. If patients re-present to the ED, they can not be re-enrolled.